Neuromodulation Devices Market Size, Share & Industry Analysis, By Product Type (Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Vagus Nerve Stimulators (VNS), Sacral Nerve Stimulators (SNS), Transcranial Magnetic Stimulators (TMS)), By Type (Invasive, and Non-invasive), By Application (Pain Management, Neurological Disorders, Respiratory Disorders), By End User (Hospitals, and Specialty Clinics), and Regional Forecast, 2019-2026 (Includes COVID-19 Business Impact)

                                          
We have updated Neuromodulation Devices Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Neuromodulation Devices market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Neuromodulation Devices market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Neuromodulation Devices Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Neuromodulation Devices Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Neuromodulation Devices Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies Profiled

Medtronic, Abbott, and LIVANOVA PLC, dominated the Market in 2018

The neuromodulation devices market is a consolidated market, with top 3-4 players accounting for more than 90% share of the market in 2018. A diverse portfolio by Medtronic, coupled with strong brand presence, widespread geographic presence, and strong distribution network, are responsible for propelling the company to leading market position in 2018. Delay in innovative product launches in spinal cord stimulation and other leading segments by Abbott and Boston Scientific Corporation has led to both players losing market share during the past few years.
LivaNova PLC, has maintained its leadership position in the sparsely contested vagus nerve stimulation devices segment through core focus and diversified product offerings. Other players in the market include electroCore, Inc., Respicardia, Inc., Inspire Medical Systems, Inc., Cefaly Technology, Neuronetics, Nuvectra, Stimwave LLC, ReShape Lifesciences, Inc., and NeuroPace, Inc., among others.
A few new entrants are engaged in clinical trials for establishing the clinical efficiency of their products in the strongly contested market. Some of these companies include Deep Brain Innovations LLC, Scion NeuroStim, and ALEVA NEUROTHERAPEUTICS SA, among others.

LIST OF KEY COMPANIES PROFILED:

  
LivaNova PLC
  
Medtronic
  
electroCore, Inc.
  
Boston Scientific Corporation
  
Abbott
  
Inspire Medical Systems, Inc.
  
Neuronetics
  
ReShape Lifesciences, Inc.
  
NeuroPace, Inc.
  
Others

KEY INDUSTRY DEVELOPMENTS:

November 2018 -electroCore Inc., a commercial stage medical devices company, received US FDA approval for its non-invasive vagus nerve stimulation (nVNS) device named gammaCore. The device received approval as an adjunct therapy for treatment of cluster headache in the U.S.

October 2017 -SenTiva, a vagus nerve stimulation device from LivaNova PLC, received US FDA approval for treatment of epilepsy. The device is approved for drug resistant epilepsy patients aged four years and above.

REPORT COVERAGE

The neuromodulation devices market report provides a detailed analysis of the market and focuses on key aspects such as leading companies, product types, types, and leading applications of the product. Besides this, the report offers insights into the market trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth of the market over the recent years.

Report Scope & Segmentation

 By Product Type

  
Spinal Cord Stimulators
  
Deep Brain Stimulators
  
Sacral Nerve Stimulators
  
Vagus Nerve Stimulators
  
Transcranial Magnetic Stimulators
  
Others

Segmentation

By Type

  
Invasive
  
Non-invasive

By Application

  
Pain Management
  
Neurological Disorders
  
Respiratory Disorders
  
Others

By End User

  
Hospitals
  
Specialty Clinics

By Geography

  
North America (U.S. and Canada)
  
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  
Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)
  
Latin America (Brazil, Mexico, and Rest of Latin America)
  
Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)